Connection

FILIP JANKU to Radionuclide Imaging

This is a "connection" page, showing publications FILIP JANKU has written about Radionuclide Imaging.
Connection Strength

0.029
  1. Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer. Invest New Drugs. 2015 Jun; 33(3):621-31.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.